Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1061-1066
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1061
Table 1 Clinical characteristics and eradication rates of the two groups n (%)
| Group Awithout PPI pretreatment(n = 573) | Group Bwith PPI pretreatment(n = 517) | P value | ||
| Age | mean ± SD (yr) | 51.8 ± 12.2 | 51.2 ± 13.4 | 0.453 |
| Sex | Male | 343 (59.9) | 351 (67.9) | 0.007 |
| Diagnosis | Iatrogenic ulcer | 31 (5.4) | 107 (20.0) | < 0.001 |
| Peptic ulcer | 438 (76.4) | 395 (77.1) | ||
| Non-ulcer disease | 104 (18.2) | 15 (2.9) | ||
| PPI in the eradication regimen | Lansoprazole 30 mg | 439 (76.6) | 410 (79.3) | 0.021 |
| Esomeprazole 40 mg | 92 (16.1) | 56 (10.8) | ||
| Rabeprazole 20 mg | 42 (7.3) | 51 (9.9) | ||
| Eradication assessment method | 13C-urea breath test | 525 (91.6) | 408 (78.9) | < 0.001 |
| Rapid urease test | 37 (6.5) | 106 (20.5) | ||
| Histological examination | 11 (1.9) | 3 (0.6) | ||
| Eradication rate | 454 (79.2) | 420 (81.2) | 0.407 | |
-
Citation: Yoon SB, Park JM, Lee JY, Baeg MK, Lim CH, Kim JS, Cho YK, Lee IS, Kim SW, Choi MG. Long-term pretreatment with proton pump inhibitor and
Helicobacter pylori eradication rates. World J Gastroenterol 2014; 20(4): 1061-1066 - URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1061.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1061